Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha H Shah

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|April 29, 2014
New era for treatment in differentiated thyroid cancerSigurdis Haraldsdottir, Manisha H Shah
Current Opinion in Oncology|November 19, 2013
An update on clinical trials of targeted therapies in thyroid cancerSigurdis Haraldsdottir, Manisha H Shah
Therapeutic Advances in Medical Oncology|July 27, 2011
Thyroid cancer: emerging role for targeted therapiesJennifer A Sipos, Manisha H Shah
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Evaluation of patients with disseminated or locoregionally advanced thyroid cancer: a primer for medical oncologistsA Dimitrios Colevas, Manisha H Shah
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
Thyroid cancer: pathogenesis and targeted therapyDavid A Liebner, Manisha H Shah
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2010
Targeting RET receptor tyrosine kinase activation in cancerJohn E Phay, Manisha H Shah
Thyroid : Official Journal of the American Thyroid Association|October 2, 2010
Prospects for small interfering RNA therapeutics in thyroid cancerSissy M Jhiang, Manisha H Shah
Endocrine-Related Cancer|February 17, 2009
New therapeutic advances in the management of progressive thyroid cancerJennifer A Woyach, Manisha H Shah
Current Opinion in Endocrinology, Diabetes, and Obesity|June 30, 2017
Endocrine dysfunction following immune checkpoint inhibitor therapyBhavana Konda, Fadi Nabhan, Manisha H Shah
Journal of the National Comprehensive Cancer Network : JNCCN|June 9, 2012
Liver-directed therapies in patients with advanced neuroendocrine tumorsNatalie B Jones, Manisha H Shah, Mark Bloomston
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|April 29, 2014
New era for treatment in differentiated thyroid cancerSigurdis Haraldsdottir, Manisha H Shah
Current Opinion in Oncology|November 19, 2013
An update on clinical trials of targeted therapies in thyroid cancerSigurdis Haraldsdottir, Manisha H Shah
Therapeutic Advances in Medical Oncology|July 27, 2011
Thyroid cancer: emerging role for targeted therapiesJennifer A Sipos, Manisha H Shah
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Evaluation of patients with disseminated or locoregionally advanced thyroid cancer: a primer for medical oncologistsA Dimitrios Colevas, Manisha H Shah
Therapeutic Advances in Endocrinology and Metabolism|November 14, 2012
Thyroid cancer: pathogenesis and targeted therapyDavid A Liebner, Manisha H Shah
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2010
Targeting RET receptor tyrosine kinase activation in cancerJohn E Phay, Manisha H Shah
Thyroid : Official Journal of the American Thyroid Association|October 2, 2010
Prospects for small interfering RNA therapeutics in thyroid cancerSissy M Jhiang, Manisha H Shah
Endocrine-Related Cancer|February 17, 2009
New therapeutic advances in the management of progressive thyroid cancerJennifer A Woyach, Manisha H Shah
Current Opinion in Endocrinology, Diabetes, and Obesity|June 30, 2017
Endocrine dysfunction following immune checkpoint inhibitor therapyBhavana Konda, Fadi Nabhan, Manisha H Shah
Journal of the National Comprehensive Cancer Network : JNCCN|June 9, 2012
Liver-directed therapies in patients with advanced neuroendocrine tumorsNatalie B Jones, Manisha H Shah, Mark Bloomston
Pageof 11